Ptc Therapeutics (PTCT) Preferred Dividend Payments (2012 - 2013)
Ptc Therapeutics' (PTCT) quarterly Preferred Dividend Payments came in at $18.2 million in Q1 2013, up 8567505.63% quarter-over-quarter from $213.0 in Q4 2012.
Ptc Therapeutics (PTCT) Preferred Dividend Payments (2012 - 2013) Analysis & Trends
Ptc Therapeutics' Preferred Dividend Payments history runs 2 years deep, the most recent figure standing at $18.2 million for Q1 2013.
- On a quarterly basis, Preferred Dividend Payments changed N/A year-over-year to $18.2 million in Q1 2013; TTM through Dec 2013 was $18.2 million, a N/A change from a year earlier, with the FY2025 full-year figure at $57.5 million, changed N/A from the prior year.
- Preferred Dividend Payments grew to $18.2 million in Q1 2013 per PTCT's latest filing, from $213.0 in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $18.2 million in Q1 2013 and bottomed at $213.0 in Q4 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Ptc Therapeutics | 6.34 Bn | 4.45 Bn | 244.52 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2013 | 18.25 Mn |
| Dec 31, 2012 | 213.00 |
| Jun 30, 2012 | 377,787.00 |